Ownership history in THOMPSON DAVIS & CO., INC. · 17 quarters on record
This page tracks every 13F SEC filing in which THOMPSON DAVIS & CO., INC. reported a position in PROFOUND MED CORP (PROF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 216,735 | +8,015 | +3.8% | 1.02% | $1.7M | $7.87 |
| 2025 Q3 | REDUCED | 208,720 | -61,800 | -22.8% | 0.63% | $1.0M | $4.89 |
| 2025 Q2 | ADDED | 270,520 | +66,670 | +32.7% | 0.70% | $1.6M | $5.90 |
| 2025 Q1 | ADDED | 203,850 | +21,555 | +11.8% | 0.94% | $1.2M | $5.82 |
| 2024 Q4 | ADDED | 182,295 | +80,395 | +78.9% | 0.88% | $1.4M | $7.51 |
| 2024 Q3 | ADDED | 101,900 | +27,100 | +36.2% | 0.60% | $811K | $7.96 |
| 2024 Q2 | ADDED | 74,800 | +6,150 | +9.0% | 0.54% | $628K | $8.39 |
| 2024 Q1 | ADDED | 68,650 | +225 | +0.3% | 0.40% | $586K | $8.53 |
| 2023 Q4 | REDUCED | 68,425 | -17,950 | -20.8% | 0.49% | $581K | $8.49 |
| 2023 Q3 | REDUCED | 86,375 | -95 | -0.1% | 1.09% | $881K | $10.20 |
As of 2025 Q4 — sorted by position size